PillClonidine
Clonidine
2 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Actavis Pharma, Inc. | unknown | 3 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 19, 2026RECALLRecall (Class II): Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufac…
CGMP Deviations: use of an unapproved raw material — Recalling firm: Teva Pharmaceuticals USA, Inc — Within U.S
- Mar 19, 2026RECALLRecall (Class II): Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufac…
CGMP Deviations: use of an unapproved raw material — Recalling firm: Teva Pharmaceuticals USA, Inc — Within U.S
- Mar 19, 2026RECALLRecall (Class II): Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufac…
CGMP Deviations: use of an unapproved raw material — Recalling firm: Teva Pharmaceuticals USA, Inc — Within U.S
- Oct 28, 2021RECALLRecall (Class III): Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT …
Failed Impurities/Degradation Specifications — Recalling firm: Teva Pharmaceuticals USA — Nationwide and Puerto Rico